We’ve got a big list for next week.  Lots of major players are reporting this week so check your Large-cap investments and keep an eye on those dates. Get your info and Get your Share here at MarketDraft. Medium-cap Small-cap Large-cap 07/28/25 WELL Welltower WM Waste Management CDNS Cadence Design Systems EPD Enterprise Products Partners… Continue reading Upcoming Quarterly Reports 7/28 – 8/1 2025 (Week 32)

Senegalese-born R&B star Akon (Aliaune Thiam) long cast himself as a champion of African development. In 2018 he announced a $6 billion “Akon City” – a futuristic, solar-powered metropolis along Senegal’s Atlantic coast – to be funded by his own digital token, Akoin. The project was backed at the highest levels: media reports noted that Senegal’s… Continue reading Akon City’s Crypto Dream Collapses in Senegal

The GENIUS Act—short for Growing and Enhancing New Innovations for UpSkilling—was passed with bipartisan support as part of a broader legislative push to strengthen the U.S. education pipeline and equip Americans with future-ready skills. The act aims to increase access to STEM education, particularly in underserved communities, and enhance partnerships between educational institutions and industry… Continue reading The GENIUS Act – The Short and Simple

We’re getting back into the reporting season so buckle up and get ready folks. Get your info and Get your Share here at MarketDraft. Medium-cap Small-cap Large-cap 07/21/25 VZ Verizon Communications ROP Roper Technologies NXPI NXP Semiconductors RYAAY Ryanair WRB W.R. Berkley STLD Steel Dynamics DPZ Domino’s Pizza ARE Alexandria Real Estate Equities CCK Crown… Continue reading Upcoming Quarterly Reports 7/21 – 7/25 2025 (Week 31)

We’re back! We hope you all had a great 4th of July and weekend! Thankfully we’re going to ease our way back into swing of things with a modest report this week.  There is a handful of Large-cap companies this week you may be interested in so take a quick peek and get ready. Get… Continue reading Upcoming Quarterly Reports 7/7 – 7/11 2025 (Week 29)

On Monday, shares of Robinhood Markets surged by more than 12% to trade near $92.76, marking the ninth consecutive week of gains and pushing the stock to levels not seen since its ostensible heyday 【finviz.com】. What began as a modest rebound has evolved into a full-fledged rally, with HOOD up over 200% since early April… Continue reading Robinhood Rockets: From IPO Lows to a 200% Rally Fueled by New Markets

With the 4th of July ahead of us, we’ve got a short week of quarterly reports to give yourselves more time to get ready for the big celebration this Friday!  If you are a Large-cap investor then pay special attention to Thursday as there are a quite a bit of activity just before we hit… Continue reading Upcoming Quarterly Reports 6/30 – 7/4 2025 (Week 27)

Stock options are financial contracts that give you the right, but not the obligation, to buy or sell a stock at a predetermined price within a specified time period. They can be powerful tools for hedging, speculating, or generating income—but they also carry significant risks. This guide will explain what stock options are, how they… Continue reading Trading Strategies: Stock Options – An Overview

In June 2025 Thailand’s cabinet approved a landmark tax waiver that effectively exempts capital gains on cryptocurrency trading for five years (Jan 1, 2025–Dec 31, 2029). The measure was adopted via a draft Ministerial Regulation under the Thai Revenue Code and is intended to promote Thailand as a regional “digital asset hub”. In practice, personal income tax on capital… Continue reading Thailand’s Five-Year Crypto Tax Exemption – What you Need to Know

Shares of telehealth and direct‐to‐consumer wellness company Hims & Hers (NYSE: HIMS) plunged more than 30 percent Monday—marking the steepest single‐day drop since going public—after pharmaceutical giant Novo Nordisk unexpectedly ended their month long collaboration to distribute Wegovy, its flagship GLP 1 weight loss medication. Hims & Hers began as a platform offering treatments for hair loss, sexual health,… Continue reading Hims & Hers Stock Plummets as Novo Nordisk Terminates Collaboration